Neuren Pharmaceuticals
NEU.asx
Neuren Pharmaceuticals (ASX:NEU) is an asset listed on the ASX, and part of the Health Care sector. Grafa’s asset page shows Neuren Pharmaceuticals’s share price, chart, trading volume, earnings per share, dividends per share and P/E ratio. You can also see how many (ASX:NEU) shares are being shorted as well as market sensitive announcements about Neuren Pharmaceuticals.
NEU share price
Last price | $13.72 | |
|---|---|---|
Change | -0.30 (-2.14%) | |
Volume | 244,866 | |
Volume traded/total % | 0.188% | |
Volume avg (4w) | 112,616 | |
Open | $14.00 | |
Day range | $13.62 - $14.00 | |
Previous Close | $14.02 | |
Last Trade | 10 Feb, 5:10 am UTC |
1 Week | 4.018% | |
|---|---|---|
1 Month | 15.197% | |
YTD | 12.505% | |
1 Year | -39.745% |
Shares Issued | 130M | |
|---|---|---|
Earnings Per Share (EPS) | $1.00 | |
Dividends Per Share (DPS) | $0.00 | |
P/E Ratio | 13.72 |
Market Cap | $1.78B | |
|---|---|---|
Market Rank | 227 | |
Industry Rank | 1 |
Set NEU.ASX share price alert
Price alerts
On Neuren Pharmaceuticals NEU.ASX dividend history
Check out Neuren Pharmaceuticals's dividend track record
Oh no, Neuren Pharmaceuticals has no dividend data to show
Key Dividend Data
-
Dividend Per Share (TTM)
-
Dividend Yield
-
Payout Ratio
-
Dividend Reinvestment Plan
| Ex-date | Amount | Franking | Type | Payable-date |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
| - | - | - | - | - |
NEU ASX Blockbusters
Latest market triggers that relate to this asset.
Dark Horse
20-day price increase: 16.89%.
5 days ago
Neuren PharmaceuticalsNEU
Neuren Pharmaceuticals
AUD$13.72
-2.14%
Price Spike
Mid cap stock spiked 2.11%.
5 days ago
Neuren PharmaceuticalsNEU
Neuren Pharmaceuticals
AUD$13.72
-2.14%
Price Spike
Mid cap stock spiked 2.28%.
5 days ago
Neuren PharmaceuticalsNEU
Neuren Pharmaceuticals
AUD$13.72
-2.14%
NEU ASX announcements
This is all recent announcements from NEU
07/02/2025 01:03 AM
priority review voucher sale proceeds received
06/02/2025 09:14 PM
type c meeting granted by fda for phelan-mcdermid syndrome
05/02/2025 10:09 PM
neuren to present at autism research meeting
21/01/2025 09:22 PM
neu presentations at acmg annual clinical genetics meeting
19/01/2025 11:14 PM
j.p. morgan healthcare conference recap
15/01/2025 11:26 PM
neuren jp morgan healthcare conference 2025 presentation
NEU news
Latest news about NEU and its peers
NEU ASX short positions
Chart shows percentage of shares on issue being shorted
Sentiment
3 Feb 2025
4.401%
of NEU shares are currently being shorted
This is higher than the Health Care sector average
Neuren Pharmaceuticals sentiment:
This Weekpositive
This Quarternegative
This Yearnegative